Krystal Biotech shares up sharply after it logs revenue from newly approved product

It's a gene-therapy treatment of a rare skin disease called dystrophic epidermolysis bullosa (DEB).

Source: bizjournals.com Health Care:Biotechnology headlines - February 26, 2024 Category: Biotechnology Authors: Paul J. Gough Source Type: news